ALVO · Alvotech

0000930413-26-001856

Summary

Alvotech terminated its ATM prospectus supplement under the Open Market Sale Agreement with Jefferies LLC, suspending potential share issuances until a new filing is made.

Key takeaways

Alvotech terminated the ATM prospectus supplement, halting share sales under the Sales Agreement, no immediate dilution.
The Sales Agreement remains in effect, but no sales will occur without a new prospectus supplement or registration statement.

Full analysis

On June 15, 2026, Alvotech notified Jefferies LLC to suspend and terminate the ATM prospectus supplement related to the potential issuance of ordinary shares. The underlying Open Market Sale Agreement remains in full force and effect, but no sales will be made until a new prospectus supplement or registration statement is filed. This move halts potential equity dilution under the ATM facility but keeps the agreement intact for future use.